Foresight® Carrier Screen

  • Foresight® Carrier Screen empowers patients with information by identifying couples at risk of passing down serious heritable conditions to their child.

  • Foresight features >99% detection rates across ethnicities for most conditions on the panel, enabling equity in care for all patients.

  • ACOG, NSGC, ACMG, and SMFM recommend Carrier Screening for all couples

Clinical Data
Health Economics
Medical Guidelines
Payer News

    Fact Sheets and Product Info:

    Executive Summary Download PDF

    Related Resources:

    1. Kaseniit K, et al. Genet Med. 2020 Oct;22(10):1694-1702.
    2. Hogan GJ. et al. Clin Chem 2018; doi:10.1373/clinchem.2018.286823.
    3. Johansen Taber KA et al., Genet Med. 2019 May;21(5):1041-1048.
    4. Edwards JG, et al. Obstet Gynecol. 2015 Mar;125(3):653-662.
    5. Obstet Gynecol. 2017 Mar;129(3):595-596.
    6. Gregg A, et al. Genet Med. 2021 Oct;23(10):1793-1806.
    7. Sagaser et al, J Genet Couns. 2023;00:1-18.

    Myriad Products

    BRACAnalysis CDx® FDA-Approved Targeted Therapies

    EndoPredict® Prognostic Breast Cancer

    Foresight® Carrier Screen

    GeneSight® Psychotropic Mental Health

    MyChoice® CDx FDA-Approved Targeted Therapies

    Myriad MyRisk® Hereditary Cancer

    Prequel™ Prenatal Screen

    Prolaris® Prognostic Prostate Cancer

    Related Content

    Contact Payer Products & Account Services
    Medicare Coverage & Medical Billing